Sequencing.com

Name

Sequencing.com

Legal name

Sequencing Inc.

Website

https://sequencing.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Direct-to-Consumer Genomics

NAICS

Web Search Portals and All Other Information Services (519290), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Whole genome sequencing
• Direct-to-consumer DNA testing
• Genetic data analysis platform
• DNA reports marketplace
• Personal genomics services

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain, Infrastructure

Revenue model

1. Whole Genome Sequencing Kits: One-time purchase of DNA sequencing kits with various service tiers (Standard, Expedited, Ultra Rapid). Includes initial DNA report analysis and access to raw genome data files.
2. Health Scan Subscription: Optional subscription for continuous genome reanalysis against latest research, providing ongoing health insights updates as new discoveries emerge.
3. DNA Reports Marketplace: Marketplace of third-party DNA reports and apps from geneticists and bioinformatics services. Users can purchase additional enhanced reports beyond included offerings.
4. Genome Plans/Membership: Subscription plans providing access to insights across health, wellness, genealogy, and professional-grade reports.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Sequencing.com is a direct-to-consumer personal genomics platform that sells 30x Whole Genome Sequencing (WGS) kits and ongoing subscriptions to interpret the resulting genetic data. Its DNA data upload service lets customers who already tested elsewhere bring raw files from 23andMe, AncestryDNA, MyHeritage, Dante Labs, and others onto the platform. Subscriptions, marketplace reports, and reanalysis tools deliver health, wellness, ancestry, medication-response, and rare-disease insights over time.

Product overview

Sequencing.com is a direct-to-consumer DNA interpretation platform offering whole genome sequencing (WGS) as its core product. The platform uses a hub-and-spoke architecture centered on 30x Whole Genome Sequencing, which generates comprehensive genetic data that feeds into multiple add-on modules including Health Scan (subscription-based continuous monitoring), Genome Explorer (genome browser), Next-Gen Rare Disease Screen (disease risk screening), and Genome Plans (subscription access to insights). Users can either purchase the WGS service or upload existing DNA data from third-party providers (23andMe, AncestryDNA, etc.) to access the platform's reports and tools. The One Genome Technology serves as the underlying data layer ensuring data accuracy across all offerings.

Differentiator

Problem solved

Functional benefit

Brands

• Genome Explorer: World's first online browser and search engine for your genome, updated weekly to include the latest genetic research.
• Next-Gen Rare Disease Screen
• Health Scan

Products and services

• Whole Genome Sequencing (WGS) Kit 30x whole genome sequencing service that reads 100% of a customer's DNA, including all ~30,000 genes and chromosomes end-to-end, analyzing over 3 billion genetic variants (SNPs, insertions, deletions, structural variations, copy-number variations). Includes the Easy-To-Use DNA Collection Kit, raw genome data files, and access to initial reports; targeted at individual consumers and physicians seeking complete genetic data.
• Health Scan Subscription Recurring subscription that continuously monitors a customer's genome against the latest scientific research and alerts them whenever new genetic discoveries may be relevant to their health. Targeted at existing WGS customers who want ongoing, up-to-date health intelligence without retesting.
• Genome Explorer Online browser and search engine for a customer's complete genome data, updated weekly with new genetic research so users can explore their DNA and discover newly relevant findings. Sold as a marketplace product to consumers and researchers who already have genome data on the platform.
• Next-Gen Rare Disease Screen Marketplace screening tool that assesses a customer's genetic risk for more than 10,000 rare diseases, conditions, and traits, with weekly updates as new research is published. Targeted at individuals and clinicians searching for explanations of unexplained symptoms or rare conditions.
• Genome Plans Subscription Subscription membership providing ongoing access to insights across health, wellness, genealogy, and professional-grade reports, including continuous reanalysis of the customer's genome as new research emerges. Targeted at existing WGS customers seeking comprehensive recurring access to platform reports.
• DNA Data Upload Free self-serve service that accepts raw DNA data uploads from more than a dozen third-party genetic testing providers and makes the data usable across the Sequencing.com platform. Targeted at individuals who have already tested with another provider and want access to Sequencing.com's reports and applications.

Quantifiable outcome

• Detects 23,975 BRCA1/2 genetic variants compared to only 3 detected by 23andMe
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration12 records

AI capability6 records

Feature5 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• 23andMe: Direct DTC genetic testing competitor offering genotyping-based ancestry and health reports. Closest comparable to Sequencing.com in business model (DTC kit + online reports), and the company Sequencing.com explicitly benchmarks against on coverage (100% vs ~0.1% of genome). Currently restructuring post-bankruptcy, making its installed base a key upload source for Sequencing.com.
• MyHeritage DNA: Direct DTC competitor offering genotyping kits with strong positioning in international genealogy markets. Comparable to Sequencing.com in DTC channel, subscription reports model, and is a supported upload source.
• AncestryDNA: DTC genetic testing service focused on genealogy and family history, with genotyping-based reports. Direct competitor in the same DTC kit channel; one of the three large incumbents Sequencing.com explicitly differentiates against on test coverage and clinical utility.
• FamilyTreeDNA: Genealogy-focused DTC genetic testing service owned by Gene by Gene, offering Y-DNA, mtDNA, and autosomal testing. Direct competitor in the genealogy segment and a supported upload source on Sequencing.com's platform.
• Helix: DTC sequencing platform offering exome-plus WGS with an app store of DNA-powered applications. Comparable on the marketplace-of-DNA-reports model (a key Sequencing.com differentiator) and on the platform-economy approach to monetizing genetic data.
• Nebula Genomics: DTC whole genome sequencing competitor founded by George Church, offering 30x WGS kits with subscription-based deep genetic analysis. Most direct competitor on the WGS technology axis, serving the same health-conscious consumer persona.
• Dante Labs: DTC whole genome sequencing provider offering 30x and higher coverage WGS kits directly to consumers. Comparable on WGS technology positioning and DTC channel; one of Sequencing.com's supported upload sources for users who tested elsewhere.

Broad incumbents

• Invitae: Large clinical genetics company offering a broad menu of germline genetic tests across many disease areas, serving clinicians and health systems. Comparable on the genetic testing services axis and on physician-ordered workflows, but operates at clinical enterprise scale rather than DTC.

Emerging players

• Orig3n: Earlier-stage DTC DNA testing company focused on wellness, fitness, and lifestyle traits. Comparable on DTC channel and direct-to-consumer health positioning, but operates at smaller scale and with narrower trait coverage than Sequencing.com.
• Color Genomics: Clinical-grade genetic testing company offering hereditary cancer, cardiovascular, and pharmacogenomics panels. Comparable in serving physicians and clinically-actionable testing; differs in using targeted panels rather than WGS, positioning it as an adjacent rather than head-to-head competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/SequencingCom
• Facebookfacebook.com/SequencingCom
• LinkedInlinkedin.com/company/sequencing-com

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sequencing.com